Download our white paper

 

Complete this form to download G-Rex bioreactors incubated in Heracell™ Vios™ CR CO₂ Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production.

 

For production of human lymphocytes for cell therapy, a contamination control strategy (CCS) is required as part of current Good Manufacturing Practices (cGMP). Evidence of successful CCS approaches will go a long way to ensuring safety, purity, efficacy and quality of a cell therapy. Microbial contamination and non-viable particulate contamination are the top two reasons for FDA injectable pharmaceuticals from 2009 to 2019.




I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information about events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

 

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com
I acknowledge Thermo Fisher Scientific (including its affiliates) will process my Personal Information according to its Privacy Policy, which includes information about my rights.


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.